The ACRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ACRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ACRX Detailed Price Forecast - CNN Money||View ACRX Detailed Summary - Google Finance|
|View ACRX Detailed Summary - Yahoo! Finance||View ACRX Stock Research & Analysis - Zacks.com|
|View ACRX Trends & Analysis - Trade-Ideas||View ACRX Major Holders - Barrons|
|View ACRX Call Transcripts - NASDAQ||View ACRX Breaking News & Analysis - Seeking Alpha|
|View ACRX Annual Report - CompanySpotlight.com||View ACRX OTC Short Report - OTCShortReport.com|
|View ACRX Fundamentals - TradeKing||View ACRX SEC Filings - Bar Chart|
|View Historical Prices for ACRX - The WSJ||View Performance/Total Return for ACRX - Morningstar|
|View the Analyst Estimates for ACRX - MarketWatch||View the Earnings History for ACRX - CNBC|
|View the ACRX Earnings - StockMarketWatch||View ACRX Buy or Sell Recommendations - MacroAxis|
|View the ACRX Bullish Patterns - American Bulls||View ACRX Short Pain Metrics - ShortPainBot.com|
|View ACRX Stock Mentions - StockTwits||View ACRX Stock Mentions - PennyStockTweets|
|View ACRX Stock Mentions - Twitter||View ACRX Investment Forum News - Investor Hub|
|View ACRX Stock Mentions - Yahoo! Message Board||View ACRX Stock Mentions - Seeking Alpha|
|View Insider Transactions for ACRX - SECform4.com||View Insider Transactions for ACRX - Insider Cow|
|View ACRX Major Holdings Summary - CNBC||View Insider Disclosure for ACRX - OTC Markets|
|View Insider Transactions for ACRX - Yahoo! Finance||View Institutional Holdings for ACRX - NASDAQ|
|View ACRX Stock Insight & Charts - FinViz.com||View ACRX Investment Charts - StockCharts.com|
|View ACRX Stock Overview & Charts - BarChart||View ACRX User Generated Charts - Trading View|
AcelRX Shares Should More Than Double On Painkiller Assets, Landenburg Says In Bullish Initiation
Posted on Thursday August 16, 2018
The company's lead candidate Dsuvia, a 30mcg sufentanil NanoTab placed sublingually by a health care professional via a single-dose applicator, is being touted as a substitute for intravenous opioids, currently the gold standard to treat moderate-to-severe pain in emergency departments, Higgins said in a Thursday note.
Edited Transcript of ACRX earnings conference call or presentation 2-Aug-18 8:30pm GMT
Posted on Tuesday August 14, 2018
Q2 2018 AcelRx Pharmaceuticals Inc Earnings Call
Is AcelRx Pharmaceuticals (ACRX) Outperforming Other Medical Stocks This Year?
Posted on Thursday August 09, 2018
Is (ACRX) Outperforming Other Medical Stocks This Year?
AcelRx Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
Posted on Wednesday August 08, 2018
REDWOOD CITY, Calif., Aug. 8, 2018 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX) (AcelRx), a specialty pharmaceutical company focused on innovative therapies for use in medically supervised settings, today announced that the underwriters of its previously announced underwritten public offering have exercised in full their option to purchase an additional 1,090,909 shares of AcelRx's common stock. Including this option exercise, total gross proceeds to AcelRx from the offering of an aggregate 8,363,636 shares at a price to the public of $2.75 per share were approximately $23.0 million, before deducting the underwriting discounts and commissions and other offering expenses payable by AcelRx. Ladenburg Thalmann acted as co-manager for the offering.